Riverwater Partners’s iRadimed IRMD Stock Holding History

Riverwater Partners’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$220K	Sell	2,285 -779	-25%	-$77.9K	0.07%	206
2025 Q4	$298K	Hold	3,064	–	–	0.12%	174
2025 Q3	$218K	Buy	+3,064	New	+$204K	0.09%	206
2025 Q1	–	Sell	-7,570	Closed	-$416K	–	218
2024 Q4	$416K	Sell	7,570 -2,549	-25%	-$134K	0.2%	119
2024 Q3	$502K	Sell	10,119 -506	-5%	-$23.3K	0.25%	109
2024 Q2	$467K	Sell	10,625 -1,129	-10%	-$48K	0.35%	83
2024 Q1	$517K	Sell	11,754 -177	-1%	-$7.82K	0.38%	75
2023 Q4	$566K	Buy	11,931 +295	+3%	+$12.4K	0.45%	62
2023 Q3	$516K	Buy	11,636 +5,402	+87%	+$251K	0.47%	62
2023 Q2	$298K	Hold	6,234	–	–	0.26%	129
2023 Q1	$245K	Buy	+6,234	New	+$227K	0.23%	147

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverwater Partners's IRMD Position: Q1 2026 in Review

Riverwater Partners reduced its iRadimed (IRMD) stake by 25% in Q1 2026, selling an estimated $77.9K and leaving 2,285 shares worth $220K. The position accounts for 0.07% of the portfolio, ranked #206.

Riverwater Partners first reported a position in IRMD in Q1 2023 and has held it in 11 quarters since. The position peaked at $566K in Q4 2023. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Riverwater Partners held 2,285 shares of iRadimed worth $220K as of Q1 2026.
Riverwater Partners sold 779 iRadimed shares in Q1 2026, an estimated $77.9K.
iRadimed made up 0.07% of Riverwater Partners's portfolio in Q1 2026, its #206 holding.
Riverwater Partners first reported a position in iRadimed in Q1 2023 and has held it in 11 quarters since.
Riverwater Partners's iRadimed position peaked at $566K in Q4 2023.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Riverwater Partners's 13F filing for Q1 2026, filed 8 May 2026.